The Johns Hopkins Institute for NanoBioTechnology (INBT) is an exceptionally diverse, multidisciplinary team of faculty, researchers, and student experts uncovering new knowledge and creating innovative technologies at the interface of nanoscience, engineering, and medicine. Launched in 2006, INBT aims to revolutionize research by fostering a collaborative environment among engineers, scientist, and clinicians to pioneer new ways to solve some of the most complex challenges in healthcare and the environment. It brings together experts from the Bloomberg School of Public Health, School of Medicine, Whiting School of Engineering, Applied Physics Lab, and Krieger School of Arts and Sciences.
INBT’s research focuses on improving and searching for new solutions to challenges in healthcare and the environment. It supports research utilizing nanoscience to advance our understanding of cellular and molecular dynamics. Researchers use this knowledge to develop novel diagnostic tools for early disease detection, study stem cells and regenerative engineering to repair damaged and diseased tissues, and engineer cancer therapies by studying cancerous cells at a precise level of detail in a three-dimensional environment